Literature DB >> 23365098

Hyaluronan accumulation and arrested oligodendrocyte progenitor maturation in vanishing white matter disease.

Marianna Bugiani1, Nienke Postma, Emiel Polder, Nikki Dieleman, Peter G Scheffer, Fraser J Sim, Marjo S van der Knaap, Ilja Boor.   

Abstract

Vanishing white matter disease is a genetic leukoencephalopathy caused by mutations in eukaryotic translation initiation factor 2B. Patients experience a slowly progressive neurological deterioration with episodes of rapid clinical worsening triggered by stress. The disease may occur at any age and leads to early death. Characteristic neuropathological findings include cystic degeneration of the white matter with feeble, if any, reactive gliosis, dysmorphic astrocytes and paucity of myelin despite an increase in oligodendrocytic density. These features have been linked to a maturation defect of astrocytes and oligodendrocytes. However, the nature of the link between glial immaturity and the observed neuropathological features is unclear. We hypothesized that the defects in maturation and function of astrocytes and oligodendrocytes are related. Brain tissue of seven patients with genetically proven vanishing white matter disease was investigated using immunohistochemistry, western blotting, quantitative polymerase chain reaction and size exclusion chromatography. The results were compared with those obtained from normal brain tissue of age-matched controls, from chronic demyelinated multiple sclerosis lesions and from other genetic and acquired white matter disorders. We found that the white matter of patients with vanishing white matter disease is enriched in CD44-expressing astrocyte precursor cells and accumulates the glycosaminoglycan hyaluronan. Hyaluronan is a major component of the extracellular matrix, and CD44 is a hyaluronan receptor. We found that a high molecular weight form of hyaluronan is overabundant, especially in the most severely affected areas. Comparison between the more severely affected frontal white matter and the relatively spared cerebellum confirms that high molecular weight hyaluronan accumulation is more pronounced in the frontal white matter than in the cerebellum. High molecular weight hyaluronan is known to inhibit astrocyte and oligodendrocyte precursor maturation and can explain the arrested glial progenitor maturation observed in vanishing white matter disease. In conclusion, high molecular weight species of hyaluronan accumulate in the white matter of patients with vanishing white matter disease, and by inhibiting glial maturation and proper function, they may be a major determinant of the white matter pathology and lack of repair.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23365098     DOI: 10.1093/brain/aws320

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  38 in total

1.  eIF2B Mutations Cause Mitochondrial Malfunction in Oligodendrocytes.

Authors:  Melisa Herrero; Shir Mandelboum; Orna Elroy-Stein
Journal:  Neuromolecular Med       Date:  2019-05-27       Impact factor: 3.843

Review 2.  Adhesion G-protein coupled receptors and extracellular matrix proteins: Roles in myelination and glial cell development.

Authors:  Paulomi Mehta; Xianhua Piao
Journal:  Dev Dyn       Date:  2017-01-11       Impact factor: 3.780

Review 3.  Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

Authors:  Natalie A Wheeler; Babette Fuss
Journal:  Exp Neurol       Date:  2016-03-23       Impact factor: 5.330

Review 4.  Dysregulation of Hyaluronan Homeostasis During White Matter Injury.

Authors:  Taasin Srivastava; Larry S Sherman; Stephen A Back
Journal:  Neurochem Res       Date:  2019-09-21       Impact factor: 3.996

5.  Astrocytes are central in the pathomechanisms of vanishing white matter.

Authors:  Stephanie Dooves; Marianna Bugiani; Nienke L Postma; Emiel Polder; Niels Land; Stephen T Horan; Anne-Lieke F van Deijk; Aleid van de Kreeke; Gerbren Jacobs; Caroline Vuong; Jan Klooster; Maarten Kamermans; Joke Wortel; Maarten Loos; Lisanne E Wisse; Gert C Scheper; Truus E M Abbink; Vivi M Heine; Marjo S van der Knaap
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

Review 6.  White matter astrocytes in health and disease.

Authors:  I Lundgaard; M J Osório; B T Kress; S Sanggaard; M Nedergaard
Journal:  Neuroscience       Date:  2013-11-11       Impact factor: 3.590

Review 7.  The environment rules: spatiotemporal regulation of oligodendrocyte differentiation.

Authors:  Sonia R Mayoral; Jonah R Chan
Journal:  Curr Opin Neurobiol       Date:  2016-04-26       Impact factor: 6.627

8.  Leukodystrophies: Five new things.

Authors:  Marjo S van der Knaap; Nicole I Wolf; Vivi M Heine
Journal:  Neurol Clin Pract       Date:  2016-12

9.  A modified flavonoid accelerates oligodendrocyte maturation and functional remyelination.

Authors:  Weiping Su; Steven Matsumoto; Fatima Banine; Taasin Srivastava; Justin Dean; Scott Foster; Peter Pham; Brian Hammond; Alec Peters; Kesturu S Girish; Kanchugarakoppal S Rangappa; Joachim Jose; Jon D Hennebold; Melinda J Murphy; Jill Bennett-Toomey; Stephen A Back; Larry S Sherman
Journal:  Glia       Date:  2019-09-06       Impact factor: 7.452

10.  ASTROCYTES: EMERGING STARS IN LEUKODYSTROPHY PATHOGENESIS.

Authors:  Angela Lanciotti; Maria Stefania Brignone; Enrico Bertini; Tamara C Petrucci; Francesca Aloisi; Elena Ambrosini
Journal:  Transl Neurosci       Date:  2013-06-01       Impact factor: 1.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.